Skip to main content
Log in

Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Abstract

The organ-specific metastasis characterizes several human cancers, including colon carcinoma, a disease that frequently involves metastases in the liver. The data on the molecular mechanisms of liver metastasis would therefore be highly useful for prognostic purposes. Although the upregulation/amplification of the hepatocyte growth factor (HGF) receptor, c-met, has been frequently observed in colon cancer metastasis, the actual functional significance of the feature in the liver metastatization is not yet known. We have used three human colon carcinoma cell lines (HT29, HT25 and WiDr), characterized by different liver metastatic potentials in SCID mice, to analyze the expression of c-met and the biological effects of HGF. We found that HGF induces scattering in in vitro liver-metastatic cell lines (HT25 and WiDr) only at doses which are non-mitogenic (1–20 ng/ml). Analysis of the c-met expression revealed that the metastatic cell lines express authentic c-met gene and protein material, unlike the non-metastatic HT29 cell line, which expresses only the c-terminal cytoplasmic domain of the c-met β-chain. Interestingly, c-met was found to be localized in the substrate-attached peripheral membrane and partially colocalized with phosphotyrosine-proteins in the metastatic cells only when kept on fibronectin. On the other hand, we have analyzed 86 primary human colon cancers in Dukes' B (invasive but non-metastatic) and C (invasive and lymph node metastatic) stages. Western blotting of the proteins isolated from the tumor tissues and immunohistochemical control study on the paraffin samples of a third of these cases (25/86) all indicated a significant upregulation of the c-met protein in the Dukes' C tumor glands compared to the Dukes' B stages (P<0.001 and P<0.05, respectively). Since the two stages differ in the involvement of the regional lymph nodes but not in the invasion depth, the clinicopathological data and our experimental findings further support the notion that the c-met expression in human colon cancer can be considered as a marker of the metastatic potential due to its involvement in the generation of the motility signal.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Radinsky R. Paracrine growth regulation of human colon carcinoma organ-specific metastasis. Cancer Metast Rev 1993; 12: 345–61.

    Article  CAS  Google Scholar 

  2. Glinsky GV. Cell adhesion and metastasis: Is the site specificity of cancer metastasis determined by leukocyte-endothelial cell recognition and adhesion. Crit Rev Oncol Hematol 1993; 14: 229–78.

    PubMed  CAS  Google Scholar 

  3. Nicolson GL. Paracrine/autocrine growth mechanisms in tumor metastasis. Oncol Res 1992; 4: 389–99.

    PubMed  CAS  Google Scholar 

  4. Cohen AM, Minsky BR, Schilsky RI. Cancer of the colon. In DeVita VT, Hellman S, Rosenberg SA (eds): Principles & Practice of Oncolgy, fifth edition. Philadelphia: Lippincott-Raven Publishers 1997; 1144–62.

    Google Scholar 

  5. Györfi T, Tímár J, Lapis K. Liver-metastatic human colon carcinoma in immunosuppressed mice. Neoplasma 1991; 38: 49–55.

    PubMed  Google Scholar 

  6. Paku S, Rot A, Ladányi A et al. Demonstration of the organ preference of liver selected high metastatic Lewis lung tumor cell line. Clin Exp Metastasis 1989; 7: 599–607.

    Article  PubMed  CAS  Google Scholar 

  7. Yasui N, Sakamoto M, Ochiai A et al. Tumor growth and metastasis of human colorectal cancer cell lines in SCID mice resemble clinical metastatic behaviors. Invasion Metastasis 1997; 17: 259–69.

    PubMed  CAS  Google Scholar 

  8. Tóvári J, Paku S, Rásó E et al. Role of sinusoidal heparan sulphate proteoglycan in liver metastasis formation. Int J Cancer 1997; 71: 825–31.

    Article  PubMed  Google Scholar 

  9. Tímár J, Ladányi A, Lapis K et al. Differential expression of proteoglycans on the surface of human melanoma cells characterized by altered experimental metastatic potential. Am J Pathol 1992; 141: 467–74.

    PubMed  Google Scholar 

  10. Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440–3.

    Article  PubMed  CAS  Google Scholar 

  11. Rosen EM, Nigam SK, Goldberg ID. Scatter factor and the c-met receptor: A paradigm for mesenchymal/epithel interaction. J Cell Biol 1994; 127: 1783–7.

    Article  PubMed  CAS  Google Scholar 

  12. Boros P, Miller CM. Hepatocyte growth factor: A multifocal cytokine. Lancet 1995; 345: 293–5.

    Article  PubMed  CAS  Google Scholar 

  13. Bottaro DP, Rubin JS, Faletto DL et al. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802–4.

    PubMed  CAS  Google Scholar 

  14. Deakin J, Lyon M. Differential regulation of hepatocyte growth factor/ scatter factor by cell surface proteoglycans and free glycosaminoglycan chains. J Cell Sci 1999; 112: 1999–2009.

    PubMed  CAS  Google Scholar 

  15. Fujita S, Sugano K. Expression of c-met proto-oncogene in primary colorectal cancer and liver metastases. Jpn J Clin Oncol 1997; 27: 378–83.

    Article  PubMed  CAS  Google Scholar 

  16. Herzig K. Functional expression of HGF and its receptor in human colorectal cancer. Digestion 2000; 61: 237–46.

    Article  PubMed  Google Scholar 

  17. Umeki K, Shoita G, Kawasaki H. Clinical significance of c-met oncogene alterations in human colorectal cancer. Oncology 1999; 56: 314–21.

    Article  PubMed  CAS  Google Scholar 

  18. Di Renzo MF, Olivero M, Giacomini A et al. Overexpression and amplification of Met/HGF receptor gene durig the progression of colorectal cancer. Clin Cancer Res 1995; 1: 147–54.

    PubMed  CAS  Google Scholar 

  19. Duh FM, Scherer SW, Tsui LC et al. Gene structure of the human MET proto-oncogene. Oncogene 1997; 15: 1583–6.

    Article  PubMed  CAS  Google Scholar 

  20. Singh RK, Radinsky R. Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. Clin Exp Metastasis 1997; 15: 140–50.

    Article  PubMed  CAS  Google Scholar 

  21. Tajima H, Matsumoto K, Nakamura T. Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 1992; 202: 423–31.

    Article  PubMed  CAS  Google Scholar 

  22. Jiang WG, Hallett MB, Puntis MCA. Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 1993; 80: 1368–73.

    PubMed  CAS  Google Scholar 

  23. Imai J, Watanabe M, Sasaki M et al. Induction of c-met protooncogene expression at the metastatic site. Clin Exp Metastasis 1999; 17: 457–62.

    Article  PubMed  CAS  Google Scholar 

  24. Nakayama Y, Okazaki K, Shibao K et al. Alterative expression of the collagenase and adhesion in the highly metastatic clones of human colonic cancer cell lines. Clin Exp Metastasis 1998; 16: 461–9.

    Article  PubMed  CAS  Google Scholar 

  25. Rong S, Segal S, Anver M et al. Invasiveness and metastasis of NIH 3T3 cells induced by Met-Hepatocyte growth factor / scatter factor autocrine stimulation. Proc Natl Acad Sci USA 1994; 91: 4731–5.

    Article  PubMed  CAS  Google Scholar 

  26. Jeffers M, Fiscella M, Webb CP et al. The mutationally activated Met receptor mediates motility and metastasis. Proc Natl Acad Sci USA 1998; 95: 14417–22.

    Article  PubMed  CAS  Google Scholar 

  27. Matsumoto K, Nakamura T, Kramer RH. Hepatocyte growth factor/scatter factor induces tyrosine phophorilation of focal adhesion kinase (p125 FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 1994; 269: 31807–13.

    PubMed  CAS  Google Scholar 

  28. Sun XF, Ekberg H, Zhang H et al. Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma. APMIS 1998; 106: 657–64.

    Article  PubMed  CAS  Google Scholar 

  29. Fredersdorf S, Burns J, Milne AM et al. High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 1997; 93: 6380–5.

    Article  Google Scholar 

  30. Tanigawa S, Hirokazu A, Matsumura M et al. Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 1997; 57: 1043–6.

    PubMed  CAS  Google Scholar 

  31. Duffy MJ. Proteases as prognostic markers in cancer. Clin Cancer Res 1996; 2: 613–8.

    PubMed  CAS  Google Scholar 

  32. Parsons SL, Watson SA, Collins HM et al. Gelatinase (MMP-2 and-9) expression in gastrointestinal malignancy. Br J Cancer 1998; 78: 1495–502.

    PubMed  CAS  Google Scholar 

  33. Nakamori S, Watanabe H, Kameyama M et al. Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence. Cancer 1994; 74: 1855–62.

    Article  PubMed  CAS  Google Scholar 

  34. Goodinson S, Tarin D. Clinical implications of anomalous CD44 gene expression in neoplasia. Front Biosci 1998; 3: 89–109.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fazekas, K., Csuka, O., Köves, I. et al. Experimental and clinicopathologic studies on the function of the HGF receptor in human colon cancer metastasis. Clin Exp Metastasis 18, 639–649 (2000). https://doi.org/10.1023/A:1013136303880

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013136303880

Navigation